Product Information
BENICAR HCT 40-25 MG TABLET is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $15.6513 per EA under NDC 00713086530. Its NADAC has been published 180 times since Jan 18, 2023.
Strength
25; 40 mg/1; mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713086530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
New Drug (NDA)
FDA Application
NDA021532On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BENICAR HCT 40-25 MG TABLET has been published 180 times since Jan 18, 2023, and over the history we have for it it has risen 31.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.6513 per EA |
|---|---|
| All-time high | $15.7729 (Mar 11, 2026) |
| All-time low | $11.8660 (Jan 18, 2023) |
| 52-week high | $15.7729 |
| 52-week low | $14.2356 |
| Median price | $14.1930 |
| Average price | $13.7509 |
| Largest weekly change | +10.0% (Sep 25, 2024) |
| Weeks tracked | 180 |
| Tracking since | Jan 18, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the olmesartan medoxomil-hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BENICAR HCT 40-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENICAR HCT 40-25 MG TABLET, manufactured by Cosette Pharmaceuticals, Inc., is $15.6513 per EA (NDC 00713086530), effective Jun 24, 2026.
How has the price of BENICAR HCT 40-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENICAR HCT 40-25 MG TABLET has risen 31.9%. It has been tracked across 180 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for BENICAR HCT 40-25 MG TABLET?
Since Jan 18, 2023, the NADAC for BENICAR HCT 40-25 MG TABLET has ranged from a low of $11.8660 (Jan 18, 2023) to a high of $15.7729 (Mar 11, 2026), with a median of $14.1930 per EA.
Are there cheaper alternatives to BENICAR HCT 40-25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BENICAR HCT 40-25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures BENICAR HCT 40-25 MG TABLET?
BENICAR HCT 40-25 MG TABLET (NDC 00713086530) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification